Source comparison
Tesamorelin + Ipamorelin Blend: Dosing Comparison Across Age Groups
30–45 years 1mg + 200mcg nightly 4 weeks 220–280 Medical history review only Younger populations tolerate standard dosing with minimal titration. Receptor density and hepatic clearance are optimal 46–59 years 6–8 weeks 200–250 ECG if cardiac risk factors prese
This comparison does not assign a generated winner or score.
- 30–45 years
- 1mg + 200mcg nightly
- 4 weeks
- 220–280
- Medical history review only
- Younger populations tolerate standard dosing with minimal titration. Receptor density and hepatic clearance are optimal
- 46–59 years
- 6–8 weeks
- 200–250
- ECG if cardiac risk factors present
- Moderate caution warranted. Slower titration prevents oedema in those with declining renal function
- 60+ years
- 0.5mg + 100mcg (weeks 1–4), then 1mg + 200mcg (weeks 5–12)
- 8–12 weeks
- 180–220
- Echocardiogram + stress test if prior cardiac history or diabetes >10 years
- Age-adjusted dosing is non-negotiable. Reduced receptor sensitivity and cardiovascular reserve require extended observation